Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease - Results from the atherogene study

Circulation Journal

Volumn 75, Issue 5, 2011, Pages 1184-1191

  Sinning, Christoph R ^a   Sinning, Jan Malte ^b   Schulz, Andreas ^a   Schnabel, Renate B ^a   Lubos, Edith ^a   Wild, Philipp S ^c   Papassotiriou, Jana ^c   Bergmann, Andreas ^c   Blankenberg, Stefan ^a   Munzel, Thomas ^a   Bickel, Christoph ^d  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c THERMO FISHER SCIENTIFIC   (Germany)

^d BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

Author keywords

Biomarkers; Coronary artery disease; Epidemiology

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; SURVIVAL;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS; SURVIVAL RATE;

EID: 79955684070     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0638     Document Type: Article

References (35)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-518.
2. Clec'h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32: 1166-1169.
3. Lee YJ, Park CH, Yun JW, Lee YS. Predictive comparisons of procalcitonin (PCT) level, arterial ketone body ratio (AKBR), APACHE III score and multiple organ dysfunction score (MODS) in systemic inflammatory response syndrome (SIRS). Yonsei Med J 2004; 45: 29-37.
4. Meisner M. Biomarkers of sepsis: Clinically useful? Curr Opin Crit Care 2005; 11: 473-480.
5. Wunder C, Eichelbronner O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 2004; 53: 158-163.
6. Oberhoffer M, Vogelsang H, Russwurm S, Hartung T, Reinhart K. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999; 37: 363-368.
7. Hoffmann G, Czechowski M, Schloesser M, Schobersberger W. Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002; 30: 2091-2095.
8. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004; 32: 1715-1721.
9. Wiedermann FJ, Kaneider N, Egger P, Tiefenthaler W, Wiedermann CJ, Lindner KH, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med 2002; 30: 1112-1117.
10. Bugden SA, Coles C, Mills GD. The potential role of procalcitonin in the emergency department management of febrile young adults during a sustained meningococcal epidemic. Emerg Med Australas 2004; 16: 114-119.
11. Chiwakata CB, Manegold C, Bonicke L, Waase I, Julch C, Dietrich M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with plasmodium falciparum malaria. J Infect Dis 2001; 183: 1161-1164.
12. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000; 28: 1828-1832.
13. Ilhan F, Akbulut H, Karaca I, Godekmerdan A, Ilkay E, Bulut V. Procalcitonin, C-reactive protein and neopterin levels in patients with coronary atherosclerosis. Acta Cardiol 2005; 60: 361-365.
14. Ataoglu HE, Yilmaz F, Uzunhasan I, Cetin F, Temiz L, Doventas YE, et al. Procalcitonin: A novel cardiac marker with prognostic value in acute coronary syndrome. J Int Med Res 2010; 38: 52-61.
15. Kelly D, Khan SQ, Dhillon O, Quinn P, Struck J, Squire IB, et al. Procalcitonin as a prognostic marker in patients with acute myocardial infarction. Biomarkers 2010; 15: 325-331.
16. Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, et al. Procalcitonin in acute myocardial infarction. Acute Card Care 2008; 10: 30-36.
17. Remskar M, Horvat M, Hojker S, Noc M. Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 2002; 114: 205-210.
18. Senturk T, Cordan J, Baran I, Ozdemir B, Gullulu S, Aydinlar A, et al. Procalcitonin in patients with acute coronary syndrome: Correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 2007; 62: 135-141.
19. Wilson PW, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, O'Donnell CJ. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 2008; 1: 92-97.
20. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172; discussion 207-212.
21. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2009.
22. Dai DF, Hwang JJ, Lin JL, Lin JW, Hsu CN, Lin CM, et al. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease. Circ J 2008; 72: 1316-1323.
23. Kato R, Momiyama Y, Ohmori R, Tanaka N, Taniguchi H, Arakawa K, et al. Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention. Circ J 2009; 73: 152-157.
24. Kim DH, Shim JK, Hong SW, Cho KR, Kang SY, Kwak YL. Predictive value of C-reactive protein for major postoperative complications following off-pump coronary artery bypass surgery: Prospective and observational trial. Circ J 2009; 73: 872-877.
25. Shimada K, Fujita M, Tanaka A, Yoshida K, Jisso S, Tanaka H, et al. Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese Coronary Artery Disease (JCAD) study. Circ J 2009; 73: 78-85.
26. Sinning JM, Bickel C, Messow CM, Schnabel R, Lubos E, Rupprecht HJ, et al. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: The Atherogene study. Eur Heart J 2006; 27: 2962-2968.
27. de Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25: 607-613.
28. Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006; 10: R1.
29. Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002; 28: 1094-1102.
30. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24: 680-684.
31. Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-2363.
32. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999; 134: 49-55.
33. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000; 28: 950-957.
34. Schlitt A, Heine GH, Blankenberg S, Espinola-Klein C, Dopheide JF, Bickel C, et al. Cd14+cd16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 2004; 92: 419-424.
35. Reilly MP, Rohatgi A, McMahon K, Wolfe ML, Pinto SC, Rhodes T, et al. Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. J Investig Med 2007; 55: 26-35.